Genome&Co

KOBIOLABS

This company develops microbiome-derived therapeutics and live biotherapeutic products for patients with immune, metabolic, neurological and gastrointestinal diseases.

mbiomics

This company develops live bacterial therapeutics and a microbiome profiling platform to treat patients with cancer and inflammatory bowel diseases.

Microbiotica

This company develops live bacterial therapeutics and biomarkers for patients with inflammatory bowel disease and advanced melanoma.

Kanvas Biosciences

This company develops microbiome mapping platforms and live biotherapeutic products for pharmaceutical companies and research institutions focused on treating cancer and inflammatory diseases.

giinnovation

This biotechnology firm develops protein-based therapeutics and immuno-oncology drugs for pharmaceutical partners and patients with cancer or allergic diseases.

Concerto BioSciences

This company develops microbe-based ingredients and therapeutics for skincare and healthcare companies using a combinatorial screening platform to map microbial interactions.

Human Biome

This biotechnology firm develops gut microbiota-based biotherapeutics and fecal microbiota transplantation preparations for medical professionals treating gastrointestinal infections and antibiotic resistance.

geninus

This company provides genomic analysis solutions and single-cell diagnostic platforms for pharmaceutical firms, healthcare providers and clinical researchers to enable precision medicine.